Safety and efficacy of agomelatine in children and adolescents with major depressive disorder receiving psychosocial counselling: a double-blind, randomised, controlled, phase 3 trial in nine countries

Celso Arango, Jan K. Buitelaar, Jörg M. Fegert, Valérie Olivier, Pierre‐François Pénélaud, Ute C. Marx, Damien Chimits, Bruno Falissard, J. Barylnik, Laura Birdeanu, Gert P Bosch, Julia Boychevskaya, Igor Boyev, Enikõ Bugán, O.A. Bukhanovskaya, Олег Чабан, Iuliana Dobrescu, Gábor Feller, Halina Flisiak-Antonijczuk, Magdolna Gácser, E.A. Grigorieva, Timo Holttinen, Svetlana Ivanović-Kovačević, Krisztina Kapornai, Л.Н. Касимова, Evgeniy Koren, Igor Martsenkovsky, N. Maruta, Mirela Matican, Tetiana Matkovska, Ellina Melnyk, Milica Pejović-Milovančević, O.P. Mostova, Péter Nagy, Laura Alexandra Nussbaum, Petar Petrov, Bożena Pietraszczyk-Kędziora, Nadia Polnareva, Elena Predescu, Vladislava Razsolkova, Filip Rybakowski, Sofiia Rymsha, Juan Schronen, Dmitrii Shigashov, A. M. Skrypnikov, Miodrag Stanković, Dejan Stevanović, Markku Timonen, Juha-Matti Väänänen, Jannie van der Westhuizen, Gert van Niekerk, Олена Венгер, Anatolii Voloshchuk, Tomasz Wolańczyk